Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso)

BMC Infectious Diseases

Robert Tinga Guiguemde²  Dramane Bayane³  Sanata Bamba²  Guekoun Lougue¹  Ibrahim Sangare²  Mamoudou Cisse² 

[1] Centre MURAZ, Bobo-Dioulasso, Burkina Faso;Institut Supérieur des sciences de la Santé, Université Polytechnique de Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso;District sanitaire de Dafra, Bobo-Dioulasso, Burkina Faso

关键词: Burkina Faso;    Risk factors;    Pregnancy;    Prevalence;    Malaria;   

Others  :  1121985
DOI  :  10.1186/s12879-014-0631-z

 received in 2014-04-28, accepted in 2014-11-11,  发布年份 2014

【 摘 要 】

Background

Malaria during pregnancy remains a serious public health problem. The aim of this study was to determine the prevalence and possible risk factors for malaria in pregnant women attending antenatal clinic at two primary health facilities in Bobo-Dioulasso.

Methods

We conducted a cross sectional study from September to December 2010 in two primary health facilities located in the periurban area of Bobo-Dioulasso. Pregnant women attending antenatal clinic (ANC) were included in the study after signing informed consent. For each participant, the social-demographic profile, malaria and obstetric histories were investigated through a questionnaire. Peripheral blood was collected and thick and thin blood smears were prepared to check Plasmodium falciparum parasitaemia. Hemoglobin concentration was measured. The associations between age, parity, gestational age, schooling, number of ANC visits, use of IPTp-SP, use of insecticide-treated nets (ITN) and anemia with the occurrence of P. falciparum malaria infection during pregnancy were analyzed through logistic regression.

Results

During the period of study, 105 (18.1%) out of 579 pregnant women were infected by P. falciparum. The hemoglobin concentration mean was 10.5 ± 1.7/dL and was significantly lower in pregnant women with malaria infection (9.8 g/dL ±1.6) than in those who had no malaria infection (10.6 g/dL ±1.7) (P < 0.001). Multivariate analysis indicated that, education (AOR 1.9, 95% CI = [1.2-3.2]), parity [primigravidae (AOR 5.0, 95% CI = [2.5-9.8]) and secundigravidae (AOR 2.1, 95% CI = [1.2-3.8])], and anaemia (AOR 2.1, 95% CI = [1.3-3.5]) were significantly associated with P. falciparum malaria infection. The use of IPTp-SP was not associated with P. falciparum malaria infection.

Conclusions

P. falciparum malaria infection is common in pregnant women attending antenatal clinic and anaemia is an important complication. The results show that the use of IPTp-SP does not reduce the risk of malaria incidence during pregnancy.

【 授权许可】

   
2014 Cisse et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Steketee RW, Nahlen BL, Parise MEMC: The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001, 64:28-35.
• [2]Brabin BJ: An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983, 61:1005-1016.
• [3]A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region World Health Organization Regional Office for Africa, AFR⁄MAL⁄04⁄01 2004.
• [4]Ministère de la santé Burkina Faso: Annuaire Statistique 2011. Ouagadougou: 2012.
• [5]Sirima SB, Cotte AH, Konaté A, Moran AC, Asamoa K, Bougouma EC, Diarra A, Ouédraogo A, Parise ME, Newman RD: Malaria prevention during pregnancy: Assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela district, Burkina Faso. Am J Trop Med Hyg 2006, 75(2):205-211.
• [6]Gies S, Coulibaly SO, Ouattara FT, Ky C, Brabin BJ, D’Alessandro U: A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso. Malar J 2008, 7:180. BioMed Central Full Text
• [7]Gies S, Coulibaly SO, Ouattara FT, D’Alessandro U: Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight. Trop Med Int Health 2009, 14(2):174-182.
• [8]Ouédraogo A, Bougouma EC, Diarra A, Konaté A, Nébié I, Tiono B, Sirima SB: Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso. Med Mal Infect 2008, 38(4):180-186.
• [9]Tiono AB, Ouedraogo A, Bougouma EC, Diarra A, Konaté AT, Nébié I, Sirima SB: Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens. Malar J 2009, 8:224. BioMed Central Full Text
• [10]Valea I, Tinto H, Drabo MK, Huybregts L, Henry M, Roberfroid D, Guiguemde RT, Kolsteren P, Alessandro UD: Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes. Malar J 2010, 9(1):324.
• [11]Valea I, Tinto H, Drabo MK, Huybregts L, Sorgho H, Ouedraogo J, Guiguemde RT, Geertruyden JP, Kolsteren P, Alessandro UD: An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso. Malar J 2012, 11:71. BioMed Central Full Text
• [12]Douamba Z, Bisseye C, Djigma FW, Compaore TR, Bazie T, Pietra V, Nikiema JB, Simpore J: Asymptomatic malaria correlates with anaemia in pregnant women at Ouagadougou, Burkina Faso. J Biomed Biotechnol 2012, 2012:198317.
• [13]Kattenberg JH, Tahita CM, Versteeg IAJ, Tinto H, Traore M, Alessandro UD, Schallig HD MP, Mens PF: Evaluation of antigen detection tests, microscopy, and polymerase chain reaction for diagnosis of malaria in peripheral blood in asymptomatic pregnant women in Nanoro, Burkina Faso. Am J Trop Med Hyg 2012, 87(2):251-256.
• [14]Kattenberg JH, Tahita CM, Versteeg I, Tinto H, Traore Coulibaly M, Schallig HD MP: Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso and the implications for the diagnosis of malaria in pregnancy. Trop Med Int Health 2012, 17:550-557.
• [15]Bamba S, Séré A, Nikiéma R, Halidou T, Thiéba B, Dao B, Guiguemdé RT: Intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso. Pan Afr Med J 2013, 14:105.
• [16]Coulibaly SO, Kayentao K, Taylor S, Guirou E, Khairallah C, Guindo N, Djimde M, Bationo R, Soulama A, Dabira E, Barry B, Niangaly M, Diakite H, Konate S, Keita M, Traore B, Meshnick SR, Magnussen P, Doumbo OK, ter Kuile FO: Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J 2014, 13:41. BioMed Central Full Text
• [17]Miaffo C, Some F, Kouyate B, Jahn AMO: Malaria and anemia prevention in pregnant women of rural Burkina Faso. BMC Pregnancy Childbirth 2004, 4(1):18. BioMed Central Full Text
• [18]Tako EA, Zhou A, Lohoue J, Leke R, Taylor DW, Leke RFG: Risk factors for placental malaria and its effect on pregnancy outcome in Yaounde, Cameroon. Am J Trop Med Hyg 2005, 72(3):236-242.
• [19]Rogerson SJ, Broek NR, Vanden , Chaluluka E, Qongwane C, Mhango CG, Molyneux ME: Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med Hyg 2000, 62(3):335-340.
• [20]Saute F, Menendez C, Mayor A, Aponte J, Gomez-olive X, Dgedge M, Alonso P: Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop Med Int Health 2002, 7(1):19-28.
• [21]Dicko A, Mantel C, Aly M, Doumbia S: Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara. Mali Acta Trop 2003, 89:17-23.
• [22]Bouyou-akotet MK, Ionete-collard DE, Mabika M, Kendjo E, Matsiegui PB, Mavoungou E, Kombila M: Prevalence of Plasmodium falciparum infection in pregnant women in Gabon. Malar J 2003, 7:1-7.
• [23]Adam I, Khamis AH, Elbashir MI: Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women of eastern Sudan. Malar J 2005, 4:4-7. BioMed Central Full Text
• [24]Osei Tutu E, Lawson B, Browne E: The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso District of Ashanti Region, Ghana. Malar J 2011, 10:385. BioMed Central Full Text
• [25]Campos PA, Valente B, Campos RB, Gonçalves L, Rosário VE: Plasmodium falciparum infection in pregnant women attending antenatal care in Luanda, Angola. Rev Soc Bras Med Trop 2012, 45(3):369-374.
• [26]Singh N, Singh MP, Wylie BJ, Hussain M, Kojo YA, Shekhar C, Sabin L, Desai M: Malaria prevalence among pregnant women in two districts with differing endemicity in Chhattisgarh, India Neeru. Malar J 2012, 11:274. BioMed Central Full Text
• [27]Fleming AF: Tropical obstetrics and gynecology. Anemia in pregnancy in Tropical Africa. Trans R Soc Trop Med Hyg 1989, 83:441-448.
• [28]Matteelli A, Donato F, Shein A: Malaria and anemia in pregnant women in urban Zanzibar, Tanzania. Ann Trop Med Parasitol 1994, 88(5):475-483.
• [29]Van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, Kuile FO: Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009–11. Lancet Infect Dis 2013, 13(12):1029-1042.
• [30]D’Almeida TC, Agboton-Zoumenou M-A, Garcia A, Massougbodji A, Briand V, Imorou Y, Cottrell G: Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation. Parasit Vectors 2011, 4:108. BioMed Central Full Text
• [31]Anchang-kimbi JK, Achidi EA, Apinjoh TO, Mugri RN, Chi HF, Tata RB, Nkegoum B, Mendimi JN, Sverremark-ekström E, Troye-blomberg M: Antenatal care visit attendance, intermittent preventive treatment during pregnancy (IPTp) and malaria parasitaemia at delivery. Malar J 2014, 13:162. BioMed Central Full Text
• [32]Bouyou-Akotet MK, Mawili-Mboumba DP, Kombila M: Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon. BMC Pregnancy childbirth 2013, 13:52. BioMed Central Full Text
• [33]Menendez C, Fleming AF, Alonso PL: Malaria-related anaemia. Parasitol Today 2000, 16:469-476.
• [34]Newman RD, Hailemariam A, Jimma D, Degifie A, Kebede D, Rietveld AEC, Nahlen BL, Barnwell JW, Steketee RW: Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a nonepidemic year. J Infect Dis 2003, 187(11):1765-1772.
• [35]Menendez C: Malaria during pregnancy: A priority area of malaria research and control. Parasitol Today 1995, 11:178-183.